Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Chronic Heart Failure

Free Subscription 10.06.2019 1 Am Heart J 3 Circ Arrhythm Electrophysiol 4 Circ Heart Fail 1 Circ Res 2 Circulation 1 Eur J Heart Fail 1 Hypertension 4 Int J Cardiol 1 J Am Coll Cardiol 4 J Card Fail 1 J Cardiovasc Pharmacol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am Heart J

1. LINDENFELD J, Abraham WT, Maisel A, Zile M, et al
   Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF).
   Am Heart J. 2019;214:18-27.
   PubMed     Text format    
   
   

   
   Circ Arrhythm Electrophysiol

2. LIANG JJ, Santangeli P
   Medical Versus Implanted Device Therapy for Patients With Heart Failure With Reduced Ejection Fraction.
   Circ Arrhythm Electrophysiol. 2019;12:e007455.
   PubMed     Text format    
   
   
3. TSENG AS, Kunze KL, Lee JZ, Amin M, et al
   Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction.
   Circ Arrhythm Electrophysiol. 2019;12:e006951.
   PubMed     Text format     Abstract available
   
   
4. PACKER M
   Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients With Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator.
   Circ Arrhythm Electrophysiol. 2019;12:e007430.
   PubMed     Text format    
   
   

   
   Circ Heart Fail

5. GRIFFIN JM, Maurer MS
   Cardiac Amyloidosis A Rare Disease in Older Adults Hospitalized for Heart Failure?
   Circ Heart Fail. 2019;12:e006169.
   PubMed     Text format    
   
   
6. RAO VS, Ahmad T, Brisco-Bacik MA, Bonventre JV, et al
   Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal Function.
   Circ Heart Fail. 2019;12:e005552.
   PubMed     Text format     Abstract available
   
   
7. BUTLER J, Zannad F, Fitchett D, Zinman B, et al
   Empagliflozin Improves Kidney Outcomes in Patients With or Without Heart Failure.
   Circ Heart Fail. 2019;12:e005875.
   PubMed     Text format     Abstract available
   
   
8. GILSTRAP LG, Dominici F, Wang Y, El-Sady MS, et al
   Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States.
   Circ Heart Fail. 2019;12:e005407.
   PubMed     Text format     Abstract available
   
   

   
   Circ Res

9. 
   Correction to: Role of SIRT1 in Modulating Acetylation of the Sarco- Endoplasmic Reticulum Ca(2+)-ATPase in Heart Failure.
   Circ Res. 2019;124:e149.
   PubMed     Text format    
   
   

   
   Circulation

10. DUNLAY SM, Givertz MM, Aguilar D, Allen LA, et al
    Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America.
    Circulation. 2019 Jun 6:CIR0000000000000691. doi: 10.1161/CIR.0000000000000691.
    PubMed     Text format     Abstract available
    
    
11. BRANCH KR, Probstfield JL, Eikelboom JW, Bosch J, et al
    Rivaroxaban With or Without Aspirin in Patients with Heart Failure and Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial.
    Circulation. 2019 Jun 5. doi: 10.1161/CIRCULATIONAHA.119.039609.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Heart Fail

12. FELKER GM, Borentain M, Cleland JG, DeSouza MM, et al
    Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure.
    Eur J Heart Fail. 2019 Jun 6. doi: 10.1002/ejhf.1504.
    PubMed     Text format     Abstract available
    
    

    
    Hypertension

13. YU Y, Cao Y, Bell B, Chen X, et al
    Brain TACE (Tumor Necrosis Factor-alpha-Converting Enzyme) Contributes to Sympathetic Excitation in Heart Failure Rats.
    Hypertension. 2019 Jun 3:HYPERTENSIONAHA11912651.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cardiol

14. SUN LY, Kimmoun A, Takagi K, Liu PP, et al
    Ethnic differences in acute heart failure outcomes in Ontario.
    Int J Cardiol. 2019 May 22. pii: S0167-5273(19)32001.
    PubMed     Text format     Abstract available
    
    
15. GENG Q, Li S, Wang Z, Ren Y, et al
    Efficacy and safety of combined neprilysin and RAS inhibition in heart failure: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2019 May 23. pii: S0167-5273(19)31213.
    PubMed     Text format     Abstract available
    
    
16. SCHAFER A, Werner N, Westenfeld R, Moller JE, et al
    Clinical scenarios for use of transvalvular microaxial pumps in acute heart failure and cardiogenic shock - A European experienced users working group opinion.
    Int J Cardiol. 2019 May 21. pii: S0167-5273(19)31855.
    PubMed     Text format     Abstract available
    
    
17. LUPON J, Cediel G, Moliner P, de Antonio M, et al
    A bio-clinical approach for prediction of sudden cardiac death in outpatients with heart failure: The ST2-SCD score.
    Int J Cardiol. 2019 May 23. pii: S0167-5273(19)31056.
    PubMed     Text format     Abstract available
    
    

    
    J Am Coll Cardiol

18. SOLOMON SD, Chatterjee NA
    Who Benefits From Implantable Cardioverter-Defibrillators?: Integrating Absolute, Proportional, and Competing Risk.
    J Am Coll Cardiol. 2017;69:2619-2621.
    PubMed     Text format    
    
    

    
    J Card Fail

19. ROWIN EJ, Romashko M, Testani JM, Koethe BC, et al
    Chronic Heart Failure is Infrequently Associated with Renal Dysfunction in Hypertrophic Cardiomyopathy.
    J Card Fail. 2019 May 31. pii: S1071-9164(19)30318.
    PubMed     Text format    
    
    
20. MARWICK TH, Huynh Q
    Risk Prediction in Heart Failure: Untranslatable or Lost in Translation?
    J Card Fail. 2019 May 31. pii: S1071-9164(19)30587.
    PubMed     Text format    
    
    
21. WARRAICH HJ, O'Connor CM, Yang H, Granger BB, et al
    African Americans with Advanced Heart Failure are More Likely to Die in a Healthcare Facility than Home or Hospice: An Analysis from the PAL-HF Trial.
    J Card Fail. 2019 May 31. pii: S1071-9164(19)30345.
    PubMed     Text format    
    
    
22. SEIF E, Sherazi S, Bravo-Jaimes K, Gosev I, et al
    Corrigendum to "Driving Pulseless: A driving survey of patients with LVADs and their providers" Journal of Cardiac Failure Vol. 25 No. 9, pp. 220-221.
    J Card Fail. 2019 May 31. pii: S1071-9164(19)30475.
    PubMed     Text format    
    
    

    
    J Cardiovasc Pharmacol

23. TOYODA S, Arikawa T, Inami S, Nishikawa R, et al
    Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED.
    J Cardiovasc Pharmacol. 2019;73:365-372.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

24. SHAMALI M, Konradsen H, Stas L, Ostergaard B, et al
    Dyadic effects of perceived social support on family health and family functioning in patients with heart failure and their nearest relatives: Using the Actor-Partner Interdependence Mediation Model.
    PLoS One. 2019;14:e0217970.
    PubMed     Text format     Abstract available
    
    
25. ZOPPINI G, Bergamini C, Mantovani A, Dauriz M, et al
    The E/e' ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies.
    PLoS One. 2018;13:e0209794.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: